Osteoprotegerin Mouse Monoclonal Antibody [9C1]
Usd: 350 Special Discount
Specification
Catalog# EM1701-98
Osteoprotegerin Mouse Monoclonal Antibody [9C1]
-
WB
-
IHC-P
-
IF-Cell
-
Human
-
Mouse
-
Rat
-
unconjugated
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_EM1701-98_Europe.pdf
- No MSDS Found
Overview
Product Name
Osteoprotegerin Mouse Monoclonal Antibody [9C1]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Recombinant protein within Human Osteoprotegerin aa 1-401 / 401.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IHC-P, IF-Cell
Target Molecular Weight
Predicted band size: 46 kDa
Positive Control
MG-63 cell lysate, Human liver tissue lysate, Mouse kidney tissue lysate, Rat heart tissue lysate, mouse kidney tissue, 293.
Conjugation
unconjugated
Clone Number
9C1
RRID
Product Features
Form
Liquid
Concentration
2 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein G affinity purified.
Application Dilution
-
WB
-
1:500-1:2,000
-
IHC-P
-
1:1,000
-
IF-Cell
-
1:50
Target
Function
Bone morphogenesis and remodeling involve the formation of bone from osteoblasts and the resorption of bone by osteoclasts. The cytokine osteoprotegerin (OPG), also designated osteoclastogenesis inhibitory factor (OCIF), is known to inhibit osteoclast formation. A secreted glycoprotein, OPG is a member of the TNF receptor family that increases bone density and volume. OPG is thought to inhibit osteoclastogenesis by disrupting the cell-to-cell signaling between osteoblastic stromal cells and osteoclast progenitors. OPG is known to bind to TRAIL, a death domain-containing protein, and to inhibit TRAIL apoptosis in Jurkat cells. OPG also binds to osteoclast differentiation factor (ODF), also known as TRANCE/RANKL, a membrane-bound protein belonging to the TNF ligand family. Both TNFα and TNFβ upregulate OPG expression, while the bone resorbing agent prostaglandin E2 downregulates OPG.
Background References
1. Tsuda E et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142 (1997).
2. Luan X et al. Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin. J Immunol 189:245-252 (2012).
Tissue Specificity
Highly expressed in adult lung, heart, kidney, liver, spleen, thymus, prostate, ovary, small intestine, thyroid, lymph node, trachea, adrenal gland, testis, and bone marrow. Detected at very low levels in brain, placenta and skeletal muscle. Highly expressed in fetal kidney, liver and lung.
Post-translational Modification
N-glycosylated. Contains sialic acid residues.; The N-terminus is blocked.
Subcellular Location
Secreted.
Synonyms
MGC29565 antibody
OCIF antibody
OPG antibody
Osteoclastogenesis inhibitory factor antibody
Osteoprotegerin antibody
PDB5 antibody
TNF receptor superfamily member 11b antibody
TNFRSF 11B antibody
TNFRSF11B antibody
TR 1 antibody
ExpandMGC29565 antibody
OCIF antibody
OPG antibody
Osteoclastogenesis inhibitory factor antibody
Osteoprotegerin antibody
PDB5 antibody
TNF receptor superfamily member 11b antibody
TNFRSF 11B antibody
TNFRSF11B antibody
TR 1 antibody
TR1 antibody
TR11B_HUMAN antibody
Tumor necrosis factor receptor superfamily member 11B antibody
CollapseImages
-
Western blot analysis of Osteoprotegerin on different lysates with Mouse anti-Osteoprotegerin antibody (EM1701-98) at 1/2,000 dilution.
Lane 1: MG-63 cell lysate
Lane 2: Human liver tissue lysate
Lane 3: Mouse kidney tissue lysate
Lane 4: Rat heart tissue lysate
Lysates/proteins at 30 µg/Lane.
Predicted band size: 46 kDa
Observed band size: 46 kDa
Exposure time: 3 minutes;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (EM1701-98) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Mouse anti-Osteoprotegerin antibody (EM1701-98) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM1701-98) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunocytochemistry analysis of 293 cells labeling Osteoprotegerin with Mouse anti-Osteoprotegerin antibody (EM1701-98) at 1/50 dilution.
Cells were fixed in 4% paraformaldehyde for 30 minutes, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes, and then blocked with 2% BSA for 30 minutes at room temperature. Cells were then incubated with Mouse anti-Osteoprotegerin antibody (EM1701-98) at 1/50 dilution in 2% BSA overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Modulating ER-mitochondrial crosstalk to revitalize implant osseointegration in diabetes through an injectable hydrogel platform
Journal: Chemical Engineering Journal
DOI: 10.1016/j.cej.2026.177208
IF: 12.5
Application: IHC
Reactivity: Rat
Publish date: 2026 May
-
A photo-responsive, fisetin-functionalized DNA nanocage for programmed therapy to accelerate early-stage wound healing in aged skin
Journal: Chemical Engineering Journal
DOI: 10.1016/j.biomaterials.2026.124330
IF: 13.2
Application: WB,IHC-P
Reactivity: Rat
Publish date: 2026 May
-
Mild Photothermal Stimulation Driven Nanoparticles Hybrid Dual-Network Hydrogels for Bone Repair
Journal: Small
DOI: 10.1002/smll.202512528
IF: 12.1
Application: WB
Reactivity: Rat
Publish date: 2026 Jan
-
Formononetin Derivative for Osteoporosis by Simultaneous Regulating Osteoblast and Osteoclast
Journal: Journal Of Natural Products
DOI:
IF: 3.3
Application: WB
Reactivity: Mouse
Publish date: 2024 Jul
-
The role of cannabinoid receptor 2 in bone remodeling during orthodontic tooth movement
Journal: BMC Oral Health
DOI: 10.1186/s12903-023-03810-5
IF: 2.6
Application:
Reactivity:
Publish date: 2024 Jan
-
Ferritin was involved in interleukin-17A enhanced osteogenesis through autophagy activation
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2023.110916
IF: 5.6
Application: WB
Reactivity: Mouse
Publish date: 2023 Sept
-
Lactobacillus coryniformis subsp. torquens inhibits bone loss in obese mice via modification of the gut microbiota
Journal: Food & Function
DOI:
IF: 6.1
Application: WB
Reactivity: Mouse
Publish date: 2023 May
-
Identification and characterization of NFATc1+ skeletal stem cells in bone regeneration
Journal: Cell Reports
DOI:
IF: 8.8
Application: IF-tissue
Reactivity: Mouse
Publish date: 2022 Nov
-
Effects of gold nanoparticles combined with human β-defensin 3 on the alveolar bone loss of periodontitis in rat
Journal: Biomedical Engineering Online
DOI:
IF: 2.812
Application: IHC-P
Reactivity: Rat
Publish date: 2021 Nov
-
Parathyroid hormone increases alveolar bone homoeostasis during orthodontic tooth movement in rats with periodontitis via crosstalk between STAT3 and β-catenin
Journal: International Journal Of Oral Science
DOI:
IF: 3.05
Application: WB,IHC-P
Reactivity: Rat
Publish date: 2020 Dec
Alternative Products
Osteoprotegerin Recombinant Rabbit Monoclonal Antibody [PSH26-52]
Application: WB,IHC-P,FC(Intra)
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Products with the same target and pathway
Human Osteoprotegerin Recombinant Rabbit Monoclonal Antibody [PSH13-32] - BSA and Azide free (Detector)
Application: ELISA(Det)
Reactivity: Human
Conjugate: unconjugated
Osteoprotegerin Recombinant Rabbit Monoclonal Antibody [PSH26-52] - BSA and Azide free
Application: WB,IHC-P,FC(Intra)
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Osteoprotegerin Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Osteoprotegerin Mouse Monoclonal Antibody [9C2]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Osteoprotegerin Recombinant Rabbit Monoclonal Antibody [PSH26-52]
Application: WB,IHC-P,FC(Intra)
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Biotin Conjugated Human Osteoprotegerin Recombinant Rabbit Monoclonal Antibody [PSH13-32] - Detector
Application: ELISA(Det),ELISA
Reactivity: Human
Conjugate: Biotin
Human Osteoprotegerin Recombinant Rabbit Monoclonal Antibody [PSH13-31] - BSA and Azide free (Capture)
Application: ELISA(Cap)
Reactivity: Human
Conjugate: unconjugated